Forgot who posted about this company last summer, but the phase III results will be released after market close today. Good luck!!
This company has like two other drug trials. one revimmune for cancer and I forget the other. Might be good for a bounce back up to $2 in anticipation of the other trials.
It bounced back from low of .70 today to $1.00. Get in and get out before they announce their second drug trial for revmimune. Good for a 2 bagger.